Clinical Trial Update: A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment [Phase 2]

View source ↗

Summary

Phase 2 dose-response trial of FE 999049 in Japanese women undergoing IVF/ICSI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• FE 999049

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility | Phase 2 | Status: COMPLETED